ChartMill assigns a Buy % Consensus number of 86% to GH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-05 | Guggenheim | Maintains | Buy -> Buy |
| 2026-01-05 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-12-22 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-15 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-12-15 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-12 | BTIG | Maintains | Buy -> Buy |
| 2025-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-30 | BTIG | Maintains | Buy -> Buy |
| 2025-10-30 | UBS | Maintains | Buy -> Buy |
| 2025-10-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-30 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-25 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-09-25 | TD Cowen | Maintains | Buy -> Buy |
| 2025-09-25 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-25 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-25 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2025-09-25 | BTIG | Maintains | Buy -> Buy |
| 2025-09-25 | UBS | Maintains | Buy -> Buy |
| 2025-09-25 | Stifel | Maintains | Buy -> Buy |
| 2025-09-25 | JP Morgan | Maintains | Overweight -> Overweight |
33 analysts have analysed GH and the average price target is 109.15 USD. This implies a price decrease of -0.88% is expected in the next year compared to the current price of 110.12.
The consensus rating for GUARDANT HEALTH INC (GH) is 86.0606 / 100 . This indicates that analysts generally have a positive outlook on the stock.